Cornea/External Disease News

NEW ORLEANS — At the ARVO meeting, Andrew D. Pucker, OD, PhD, senior director of clinical and medical sciences at Lexitas Pharma Services, speaks about the Lexitas modified NEI grading scale to assess corneal fluorescein staining.

Ideally, corneal cross-linking is offered as an early intervention for keratoconus as soon as there is evidence of progression and before significant vision loss or ectasia.

Tanfanercept did not demonstrate statistical significance in improvement in central corneal staining score or eye dryness score at week 8, the primary outcome measures of the phase 3 VELOS-3 trial, according to HanAll Biopharma.

SAN DIEGO — In this Healio Video Perspective from Eyecelerator@ASCRS, Greg Kunst, CEO of Aurion Biotech, discusses data from the Escalon clinical trial.

The FDA approved Miebo for the treatment of signs and symptoms of dry eye disease, Bausch + Lomb and Novaliq announced in a press release.

NEW YORK — A Tarsus executive said the company is looking forward to FDA approval of TP-03, a 0.25% lotilaner ophthalmic solution for treatment of Demodex blepharitis, in late summer 2023.

SAN DIEGO — In this Healio Video Perspective from Eyecelerator@ASCRS, Norbert Lowe and Michael Rowe of Eyenovia announce the FDA approval of Mydcombi, an ophthalmic spray designed to induce mydriasis.

The FDA has approved Eyenovia’s Mydcombi ophthalmic spray for inducing mydriasis, the company announced in a press release.

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Penny A. Asbell, MD, FACS, MBA, discusses antibiotic resistance in endophthalmitis.

NEW YORK — Advancements in cross-linking will involve performing the procedure with the epithelium on, Mitch Ibach, OD, FAAO, said in this Healio video from Vision Expo East.